Cargando…
GH Responsiveness to Combined GH-Releasing Hormone and Arginine Administration in Obese Patients with Fibromyalgia Syndrome
Reportedly, fibromyalgia (FM) is frequently associated with reduced IGF-1 levels and GH hyporesponsiveness to different GH stimulation tests. Since there is a high prevalence of obesity in FM, and obesity itself is characterized by hyposomatotropism, the aim of this study was to assess IGF-1 levels...
Autores principales: | Rigamonti, Antonello E., Grugni, Graziano, Arreghini, Marco, Capodaglio, Paolo, De Col, Alessandra, Agosti, Fiorenza, Sartorio, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506478/ https://www.ncbi.nlm.nih.gov/pubmed/28744309 http://dx.doi.org/10.1155/2017/3106041 |
Ejemplares similares
-
Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency
por: Patti, Giuseppa, et al.
Publicado: (2019) -
Long-term effects of GH therapy in adult patients with Prader-Willi syndrome: a longitudinal study
por: Grugni, Graziano, et al.
Publicado: (2023) -
Regulation of GH and GH Signaling by Nutrients
por: Caputo, Marina, et al.
Publicado: (2021) -
Growth hormone (GH)–releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?
por: Hersch, Elizabeth C, et al.
Publicado: (2008) -
Is Non-Alcoholic Fatty Liver Disease Less Frequent among Women with Prader-Willi Syndrome?
por: Bedogni, Giorgio, et al.
Publicado: (2014)